MARK TUFTE, OD
Corneal and Contact Management Optometrist in FARGO, North Dakota. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MARK TUFTE, OD filed 420 Medicare Part D claims in 2023 as a Corneal and Contact Management Optometrist in FARGO, North Dakota, prescribing 67% generic.
- 420
- Part D claims, 2023
- 67%
- generic prescribing
- $97.69
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MARK TUFTE, OD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
420 Top 38% higher than 62% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about MARK TUFTE, OD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in North Dakota
How Corneal and Contact Management Optometrist compares to other specialties among North Dakota providers
Corneal and Contact Management Optometrist share within North Dakota
Corneal and Contact Management Optometrist is one of the more visible NUCC categories in North Dakota
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Corneal and Contact Management Optometrist (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Corneal and Contact Management Optometrist ABMS/AOA estimate
Est. board-certified rate (Corneal and Contact Management Optometrist) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Corneal and Contact Management Optometrist US NPIs
Specialty board-certified rate — Corneal and Contact Management Optometrist estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MARK TUFTE, OD appears in the CMS NPPES registry as a Corneal and Contact Management Optometrist provider holding OD credentials at 1801 45TH ST S STE G, FARGO, ND, 58103, with a listed phone of (701) 492-3937. NPI 1669494233 was issued on 07/24/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what TUFTE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 420 prescription claims written by this provider, covering 104 Medicare beneficiaries and totaling roughly $33K in drug spend, split 33% brand-name and 67% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Corneal and Contact Management Optometrist is a narrow specialty nationwide, with 1,549 enrolled providers across 52 states and an average of 235 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1669494233 |
|---|---|
| Specialty | Corneal and Contact Management Optometrist |
| Credentials | OD |
| Gender | Male |
| NPI Issued | 07/24/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MARK TUFTE, OD's current license status, disciplinary history, and board certifications with the North Dakota Board of Medicine in North Dakota before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK TUFTE, OD. Source: openpaymentsdata.cms.gov.
Total received
$98
Largest payer
Alcon Vision LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
33% brand-name claims vs 67% generic, on 420 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 611
- Total Day Supply
- 16,489
- Brand vs Generic
- 33% brand / 67% generic
- Brand Drug Cost
- $26K
- Generic Drug Cost
- $7K
Patient Demographics
- Average Patient Age
- 73.9 years
- Avg HCC Risk Score
- 0.98
- Gender Split
- 62% female / 38% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MARK TUFTE, OD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
132 claims
- Timolol Maleate
Timolol Maleate
100 claims
- Dorzolamide-Timolol 22
Dorzolamide-Timolol
22 claims
- Dorzolamide Hcl 19
Dorzolamide Hcl
19 claims
- Neomycin-Polymyxin… 19
Neomycin-Polymyxin-Dexameth
19 claims
- Prednisolone Acetate 17
Prednisolone Acetate
17 claims
- Fluorometholone 16
Fluorometholone
16 claims
- Lumigan 15
Lumigan
15 claims
| Drug | Claims |
|---|---|
| Latanoprost | 132 |
| Timolol Maleate | 100 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 22 |
| Dorzolamide Hcl | 19 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 19 |
| Prednisolone Acetate | 17 |
| Fluorometholone | 16 |
| Lumigan Bimatoprost | 15 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 14 |
| Brimonidine Tartrate | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Corneal and Contact Management Optometrist Overview
How MARK TUFTE, OD fits within the Corneal and Contact Management Optometrist landscape nationally.
MARK TUFTE, OD's 420 claims are above the specialty average of 235.
Nearby Corneal and Contact Management Optometrist Providers in North Dakota
Other clinicians with the same primary specialty enrolled in North Dakota, drawn from the same CMS NPPES roster as TUFTE.
Compare Corneal and Contact Management Optometrist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore North Dakota
Frequently Asked Questions
What is MARK TUFTE, OD's specialty? ▼
How much does MARK TUFTE, OD prescribe under Medicare Part D? ▼
Where is MARK TUFTE, OD located? ▼
What is MARK TUFTE, OD's NPI number? ▼
Does MARK TUFTE, OD prescribe more brand-name or generic drugs? ▼
How many Corneal and Contact Management Optometrist providers are there in the US? ▼
What drugs does MARK TUFTE, OD prescribe most often? ▼
Does MARK TUFTE, OD accept Medicare? ▼
How can I verify MARK TUFTE, OD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology